Lihong Xu,Janine Stevens,Mary Beth Hilton,Steven Seaman,Thomas P. Conrads,Timothy D. Veenstra,Daniel Logsdon,Holly Morris,Deborah A. Swing,Nimit L. Patel,Joseph D. Kalen,Diana C. Haines,Enrique Zudaire,Brad St. Croix
出处
期刊:Science Translational Medicine [American Association for the Advancement of Science (AAAS)] 日期:2014-06-25卷期号:6 (242)被引量:205
Inhibition of cyclooxygenase-2 (COX-2) inhibits angiogenesis, suppresses tumor growth, and augments the effects of traditional angiogenesis inhibitors.